E-LIB Suche - Ergebnisse für: Ruiz Genao, Diana P.

1

Criteria used to define tumor necrosis factor-alpha inhibit..:

Belinchon Romero, Isabel ; Mateu Puchades, Almudena ; Ribera Pibernat, Miguel...
Annals of Medicine. 55 (2023) 1 - p. 1335-1345 , 2023

Link: https://doi.org/10.1080/..

2

Differences in epidemiology, comorbidities and treatment ch..:

Ruiz Genao, Diana P. ; Carretero, Gregorio ; Rivera-Diaz, Raquel...
British Journal of Dermatology. 187 (2022) 5 - p. 817-820 , 2022

Link: https://doi.org/10.1111/..

3

Placas eritematosas por heparina de bajo peso molecular:

Ruiz Genao, Diana P. ; Sanz SáNchez, Tatiana ; SáNchez PéRez, Javier..
Actas Dermo-Sifiliográficas. 92 (2001) 3 - p. 93-96 , 2001

Link: https://doi.org/10.1016/..

4

Criteria used to define tumor necrosis factor-alpha inhibit..:

Belinchón, Isabel ; Mateu Puchades, Almudena ; Ribera Pibernat, Miguel...
Annals of Medicine. , 2023

Link: https://ddd.uab.cat/reco..

5

Telangiectasias posradioterapia. Tratamiento con láser de c..:

Ruiz-Genao, Diana P. ; Córdoba, Susana ; José García-F-Villalta, M.ª..
Actas Dermo-Sifiliográficas. 97 (2006) 5 - p. 345-347 , 2006

Link: https://doi.org/10.1016/..

6

Infiltración cutánea por linfoma-leucemia de células T CD56:

Hernández, Almudena ; Ruiz-Genao, Diana P. ; Fraga, Javier..
Actas Dermo-Sifiliográficas. 94 (2003) 4 - p. 251-254 , 2003

Link: https://doi.org/10.1016/..

7

Effect of Sex in Systemic Psoriasis Therapy: Differences in..:

HERNÁNDEZ-FERNÁNDEZ, Carlos Pelayo ; CARRETERO, Gregorio ; RIVERA, Raquel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309850/. , 2021

Link: http://www.ncbi.nlm.nih...

8

Effect of Sex in Systemic Psoriasis Therapy: Differences in..:

Hernández-Fernández, Carlos Pelayo ; Carretero, Gregorio ; Rivera, Raquel...
http://hdl.handle.net/10668/16723. , 2021

Link: http://hdl.handle.net/10..

9

Criteria used to define tumor necrosis factor-alpha inhibit..:

Isabel Belinchon Romero ; Almudena Mateu Puchades ; Miguel Ribera Pibernat...
https://www.tandfonline.com/doi/10.1080/07853890.2023.2192957. , 2023

Link: https://doi.org/10.1080/..

10

The risk of hepatic adverse events of systemic medications ..:

Mónica Munera-Campos ; Jaime Vilar-Alejo ; Raquel Rivera...
http://dx.doi.org/10.1080/09546634.2021.1922572. , 2022

Link: https://doi.org/10.1080/..

11

Effect of Sex in Systemic Psoriasis Therapy: Differences in..:

Carlos Pelayo Hernández-Fernández ; Gregorio Carretero ; Raquel Rivera...
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3711. , 2021

Link: https://doi.org/10.2340/..

12

Super‐responders in psoriasis under interleukin 23 inhibito..:

Menéndez Sánchez, M. ; Muñiz de Lucas, A. ; Pérez Fernández, E....
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 11 - p. , 2023

Link: https://doi.org/10.1111/..

13

Caracterización y resultados de pacientes tratados con apre..:

Herranz, P. ; Trasobares, L. ; Mateu, A....
Actas Dermo-Sifiliográficas. 112 (2021) 9 - p. 817-827 , 2021

Link: https://doi.org/10.1016/..

14

Characterization and Outcomes in Patients Treated With Apre..:

Herranz, P. ; Trasobares, L. ; Mateu, A....
Actas Dermo-Sifiliográficas (English Edition). 112 (2021) 9 - p. 817-827 , 2021

Link: https://doi.org/10.1016/..

15

Delphi-based recommendations for the management of cardiova..:

Zarco Montejo, Pedro ; Almodóvar González, Raquel ; De Higes-Martínez, Eva...
Rheumatology International. 40 (2020) 6 - p. 969-981 , 2020

Link: https://doi.org/10.1007/..